RA Capital Healthcare Fund LP, 10% Owner at Fulcrum Therapeutics, Inc. (FULC), sold 8,350,278 shares at $13.33 ($116.8M) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Open-market sale of $116.8M FULC by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.33 | 1,377,020 | $18.4M | 15.7% |
| 2 | $13.33 | 1,377,020 | $18.4M | 15.7% |
| 3 | $14.28 | 2,706,397 | $38.6M | 33.1% |
| 4 | $14.28 | 2,706,397 | $38.6M | 33.1% |
| 5 | $14.98 | 91,722 | $1.4M | 1.2% |
| 6 | $14.98 | 91,722 |
| $1.4M |
| 1.2% |
| Total | $13.98 avg | 8,350,278 | $116.8M | 100% |
| Filing → |
| PEPG | BUY | 2025-09-30 | $30.0M | — | Filing → |
| TYRA | BUY | 2025-06-11 | $3.8M | — | Filing → |
| JANX | BUY | 2025-03-07 | $50.7M | — | Filing → |